Xiaoying Lei
Overview
Explore the profile of Xiaoying Lei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Chen M, Wang X, Gao Y, Han X, Wang S, et al.
Exp Cell Res
. 2024 Dec;
444(2):114389.
PMID: 39701355
In hepatocellular carcinoma (HCC), lenvatinib is a key first-line treatment that significantly improves survival in some patients with advanced stage. However, lenvatinib resistance presents a major clinical challenge. This study...
2.
Qian H, Tian L, Liu W, Liu L, Li M, Zhao Z, et al.
NPJ Vaccines
. 2024 Oct;
9(1):194.
PMID: 39426985
Severe fever with thrombocytopenia syndrome (SFTS) is caused by the SFTS virus (SFTSV) with high morbidity and mortality. The major immunodominant region of SFTSV surface glycoprotein (G) remains unclear. In...
3.
Lu Y, Liu Y, Zuo X, Li G, Wang J, Liu J, et al.
J Hepatol
. 2024 Oct;
PMID: 39393439
Background & Aims: The tumor microenvironment (TME) plays a crucial role in the limited efficacy of existing treatments for hepatocellular carcinoma (HCC), with tumor-associated endothelial cells (TECs) serving as fundamental...
4.
Xiao Y, Xiao L, Xu X, Guan X, Guo Y, Shen Y, et al.
Leuk Res
. 2024 Sep;
146:107587.
PMID: 39316991
Background: Tumor lysis syndrome (TLS) frequently manifests shortly after induction chemotherapy for acute lymphoblastic leukemia (ALL), with the potential for swift progression. This study endeavored to develop a nomogram to...
5.
Shen C, Zhang L, Meng Y, Yang L, He W, Lei X, et al.
Front Pediatr
. 2024 Aug;
12:1420118.
PMID: 39108694
Lipopolysaccharide (LPS)-responsive beige ankyrin (LRBA) gene mutations were first reported as the cause of immunodeficiency syndromes and autoimmunity in 2012. The majority of LRBA patients have multiple organ system involvement...
6.
Tong K, Meng Y, Zhang L, Lei X, Liu Q, Guan X, et al.
Ann Hematol
. 2024 May;
103(7):2485-2497.
PMID: 38709259
Cardiotoxicity in children is a potentially fatal complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT); therefore, early identification of risk factors can improve patient prognosis. However, there are few data...
7.
He L, Li Z, Su D, Du H, Zhang K, Zhang W, et al.
Adv Sci (Weinh)
. 2024 May;
11(26):e2403858.
PMID: 38704691
Cancer immunotherapy has demonstrated significant efficacy in various tumors, but its effectiveness in treating Hepatocellular Carcinoma (HCC) remains limited. Therefore, there is an urgent need to identify a new immunotherapy...
8.
Xiao Y, Xiao L, Zhang Y, Xu X, Guan X, Guo Y, et al.
Front Oncol
. 2024 Mar;
14:1337295.
PMID: 38515564
Background: Tumor lysis syndrome (TLS) often occurs early after induction chemotherapy for acute lymphoblastic leukemia (ALL) and can rapidly progress. This study aimed to construct a machine learning model to...
9.
Liu L, Zheng W, Qian H, Zhao Z, Tian L, Song Y, et al.
Int Immunopharmacol
. 2023 Oct;
124(Pt B):111005.
PMID: 37804656
Human inactivated rabies virus (RABV) vaccines have been widely used worldwide over 30 years. The mechanisms of humoral immunity elicited by previously reported rabies candidate vaccines have been fully investigated,...
10.
Ruan B, Zhu Z, Yan Z, Yang W, Zhai D, Wang L, et al.
Stem Cell Res Ther
. 2023 Sep;
14(1):275.
PMID: 37775775
No abstract available.